Burkard Natalie, Rokita Adam G, Kaufmann Susann G, Hallhuber Matthias, Wu Rongxue, Hu Kai, Hofmann Ulrich, Bonz Andreas, Frantz Stefan, Cartwright Elizabeth J, Neyses Ludwig, Maier Lars S, Maier Sebastian K G, Renné Thomas, Schuh Kai, Ritter Oliver
Department of Internal Medicine I, University of Wuerzburg, Wuerzburg, Germany.
Circ Res. 2007 Feb 16;100(3):e32-44. doi: 10.1161/01.RES.0000259042.04576.6a. Epub 2007 Feb 1.
The role of the neuronal NO synthase (nNOS or NOS1) enzyme in the control of cardiac function still remains unclear. Results from nNOS(-/-) mice or from pharmacological inhibition of nNOS are contradictory and do not pay tribute to the fact that probably spatial confinement of the nNOS enzyme is of major importance. We hypothesize that the close proximity of nNOS and certain effector molecules like L-type Ca(2+)-channels has an impact on myocardial contractility. To test this, we generated a new transgenic mouse model allowing conditional, myocardial specific nNOS overexpression. Western blot analysis of transgenic nNOS overexpression showed a 6-fold increase in nNOS protein expression compared with noninduced littermates (n=12; P<0.01). Measuring of total NOS activity by conversion of [(3)H]-l-arginine to [(3)H]-l-citrulline showed a 30% increase in nNOS overexpressing mice (n=18; P<0.05). After a 2 week induction, nNOS overexpression mice showed reduced myocardial contractility. In vivo examinations of the nNOS overexpressing mice revealed a 17+/-3% decrease of +dp/dt(max) compared with noninduced mice (P<0.05). Likewise, ejection fraction was reduced significantly (42% versus 65%; n=15; P<0.05). Interestingly, coimmunoprecipitation experiments indicated interaction of nNOS with SR Ca(2+)ATPase and additionally with L-type Ca(2+)- channels in nNOS overexpressing animals. Accordingly, in adult isolated cardiac myocytes, I(Ca,L) density was significantly decreased in the nNOS overexpressing cells. Intracellular Ca(2+)-transients and fractional shortening in cardiomyocytes were also clearly impaired in nNOS overexpressing mice versus noninduced littermates. In conclusion, conditional myocardial specific overexpression of nNOS in a transgenic animal model reduced myocardial contractility. We suggest that nNOS might suppress the function of L-type Ca(2+)-channels and in turn reduces Ca(2+)-transients which accounts for the negative inotropic effect.
神经元型一氧化氮合酶(nNOS或NOS1)在心脏功能调控中的作用仍不明确。来自nNOS基因敲除小鼠或nNOS药理学抑制的结果相互矛盾,且未考虑到nNOS酶的空间限制可能至关重要这一事实。我们推测nNOS与某些效应分子(如L型钙通道)的紧密接近对心肌收缩力有影响。为了验证这一点,我们构建了一种新的转基因小鼠模型,可实现条件性、心肌特异性nNOS过表达。对转基因nNOS过表达的蛋白质免疫印迹分析显示,与未诱导的同窝小鼠相比,nNOS蛋白表达增加了6倍(n = 12;P < 0.01)。通过将[³H]-L-精氨酸转化为[³H]-L-瓜氨酸来测量总一氧化氮合酶活性,结果显示nNOS过表达小鼠增加了30%(n = 18;P < 0.05)。经过2周诱导后,nNOS过表达小鼠的心肌收缩力降低。对nNOS过表达小鼠的体内检查显示,与未诱导小鼠相比,+dp/dt(max)降低了17±3%(P < 0.05)。同样,射血分数也显著降低(42%对65%;n = 15;P < 0.05)。有趣的是,免疫共沉淀实验表明在nNOS过表达动物中,nNOS与肌浆网钙ATP酶以及L型钙通道相互作用。因此,在成年分离的心肌细胞中,nNOS过表达细胞中的I(Ca,L)密度显著降低。与未诱导的同窝小鼠相比,nNOS过表达小鼠心肌细胞中的细胞内钙瞬变和缩短分数也明显受损。总之,在转基因动物模型中条件性心肌特异性过表达nNOS会降低心肌收缩力。我们认为nNOS可能抑制L型钙通道的功能,进而减少钙瞬变,这解释了负性肌力作用。